SMI 11’592 -1.2%  SPI 14’859 -1.4%  Dow 31’538 -3.4%  DAX 14’008 -1.3%  Euro 1.0343 -1.3%  EStoxx50 3’691 -1.4%  Gold 1’819 0.2%  Bitcoin 28’773 -4.9%  Dollar 0.9872 -0.6%  Öl 108.8 -3.6% 

Parkway Life REIT

Seite 1 von 1
neuester Beitrag: 29.01.22 08:50
eröffnet am: 27.06.19 09:20 von: Xarope Anzahl Beiträge: 21
neuester Beitrag: 29.01.22 08:50 von: Xarope Leser gesamt: 6236
davon Heute: 1
bewertet mit 0 Sternen

27.06.19 09:20

3263 Postings, 2521 Tage XaropeParkway Life REIT

was macht man wenn man einen Wert unbedingt haben will und einen Monat auf en kauf wartet, man kauft überteuert :-D
Ist zwar als long gedacht, da aber in DE schwer zu handeln hats die größe einer kleinen Zockerposi.

zu Parkway:

Parkway Life REIT ("PLife REIT") is one of Asia's largest listed healthcare REITs. It invests in income-producing real estate and real estate-related assets used primarily for healthcare and healthcare-related purposes. As at 31 March 2019, PLife REIT's total portfolio size stands at 50 properties totalling approximately S$1.86 billion.

aus: http://plifereit.com/about/

 

04.08.19 09:00

3263 Postings, 2521 Tage XaropePLife: 2Q 2019 RESULTS PRESENTATION

2Q 2019 RESULTS PRESENTATION

Doks:
https://links.sgx.com/1.0.0/...2253e6c7dead47b4ec243cc1452e4814525479

Dok der Zitate:
https://links.sgx.com/FileOpen/...?App=Announcement&FileID=572524

2Q 2019Key Highlights

Steady DPU Growth Since IPO
―DPU for 2Q 2019 at 3.27cents; DPU for 1H 2019 at 6.55cents
―DPU grew by 2.6% (2Q Y-O-Y) and 3.0% (1H Y-O-Y)

Strong Capital Structure1
―Further extended JPY net income hedge till 1Q 2024 capitalising on the recent strengthening of JPY
―No long-term debt refinancing needs till 20202
―Interest cover ratio of 13.8 times
―Gearing remains optimal at 36.9%
―All-in cost of debt of 0.91%

 

19.10.19 08:31

3263 Postings, 2521 Tage XaropePLife: moodys periodic review baa2

Moody's announces completion of a periodic review of ratings of Parkway Life REIT

https://www.moodys.com/research/...hbnNsYXRpb25z%7e20191015_PR_408719

Parkway Life REIT's (PLife REIT) Baa2 issuer rating reflects its ability to generate stable and recurring income from its healthcare properties. Majority of its properties are under long term lease agreements which provide revenue visibility as well income stability. The rating also considers the trust's financial flexibility as all its debt is unsecured.

 

07.12.19 08:38

3263 Postings, 2521 Tage XaropePLife: Acquisition of 3 Properties Located in Japa

Acquisition of Three Properties Located in Japan

https://links.sgx.com/1.0.0/...be09b30e2aec40fc7c1582dbdc320e99977f05

191203 Press Release_FINAL.pdf
https://links.sgx.com/FileOpen/...?App=Announcement&FileID=589250

Singapore, 3 December2019–Parkway Trust Management Limited (the “Manager”), as manager of Parkway Life Real Estate Investment Trust (“PLife REIT”), one of Asia’s largest listed healthcare REITs, is  pleased  to  announce the acquisition  of three  nursing rehabilitation facilities in  Japan  (collectively, the “Properties”) from K.K.Habitation, Fuyo ShojiKabushiki KaishaandMedical Corporation Shojin-kai  (collectively, the  “Vendors”)  for  a  total  consideration  of JPY3,700 million  (approximately S$46.3million3).

 

25.01.20 08:54

3263 Postings, 2521 Tage XaropePLife: Investor Presentation Slides Full Year 2019

PLife REIT Investor Presentation Slides Full Year 2019 Results

http://plifereit.listedcompany.com/newsroom/...XTC276D422REODUL.1.pdf

Steady DPU Growth Since IPO
―DPU for 4Q 2019 up 2.0% (4Q Y-O-Y) to 3.34 cents
―Full year DPU growth of 2.5% y-o-y to 13.19 cents  
―Strong growth of 108.7% since IPO

Strengthening of Japan Portfolio
―Acquisition of three nursing rehabilitation facilities at JPY3.7 billion/S$46.3 million1
―Purchase price approximately 7.0% below valuation
―Net property yield of 6.8%
―Solidified PLife REIT’s position through geographical and tenant diversification within Japan

Strong Capital Structure
―No significant debt refinancing needs in 20202
―Interest cover ratio of 14.1 times
―Gearing remains optimal at 37.1%
―About 83% of interest rate exposure is hedged
―All-in cost of debt of approximately 0.80%

Valuation Gain In Properties
―Valuation gain of $43.0 million (2.2%) of the total portfolio as at 31 December 2019

 

25.04.20 08:33

3263 Postings, 2521 Tage XaropePLife: Q1 2020 Investor Presentation Slides

Investor Presentation Slides

https://links.sgx.com/1.0.0/...4c02d9dd744096b0a08f249ffcf34e2802ce49

* Revenue grew by 5.2% to $29.9 million for 1Q 2020.

1Q 2020 Key Highlights

DPU Growth of 1.4% for 1Q 2020
―Amount available for distribution income grew by 5.7% (Y-O-Y)
―Will set aside $1.7 million for COVID-19 related relief measures to support our tenants where necessary, of which S$850,000 was retained in 1Q 2020
―Notwithstanding, DPU for 1Q 2020 grew by 1.4% (Y-O-Y) to 3.32 cents

Successful Refinancing of remaining Long Term Loan due in 2020
―Secured a 6-year committed loan facility to term out the S$75.2 million loan2in 3Q 2020
―Extended debt maturity profile to 2026
―No long term debt refinancing needs till June 2021

Strong Capital Structure
―Extended JPY net income hedge till 2Q 2025 capitalising on the recent strengthening of JPY
―Gearing remains optimal at 38.5%
―Interest coverage ratio of 14.8 times
―About 89% of interest rate exposure is hedged
―Lowered all-in cost of debt from 0.80%3to 0.63% mainly due to the extension of JPY interest rate hedge at lower cost and overall drop in interest rates

Impact of COVID-19
―Posed significant impact on the global economy since its outbreak in early 2020
―Notwithstanding, the REIT’s operations and performance are relatively stable with no major impact anticipated
―Continues to monitor the situation closely


 

01.08.20 08:41

3263 Postings, 2521 Tage XaropePLife: 2Q 2020

Investor Presentation Slides 2Q 2020

https://links.sgx.com/1.0.0/...e015276aabef2b9808b51f0b08075056b1426d


Second Quarter and/ or Half Yearly Results

https://links.sgx.com/1.0.0/...ab7c4072d2758ab412600a3399e4c250bb6827

- Amount available for distribution grew by 5.2% (2Q Y-O-Y)
- 2Q  2020  DPU  grew  2.5%  to  3.36  cents  notwithstanding  retention of  S$850k  for COVID-19 related relief measures
- All properties reported stable operations even as COVID-19 outbreak persisted
- Minimum Guaranteed Rent for Singapore Hospitals to increase by 1.17% for the 14thyear of lease term commencing 23 August 2020

Gross revenue for the periods under review recorded a year-on-year (“y-o-y”) growth of 4.9% in 2Q 2020 to S$30.3 million and a 5.1% increase in 1H 2020 to S$60.1 million, mainly due to revenue contribution from three Japan nursing rehabilitation facilities acquired in 4Q 2019, higher rent from Singapore properties as well as appreciation of the Japanese Yen (“JPY”). Net  property  income  and  amount  available  for  distribution  increased  in  line  with  gross revenue. Net property income registered a 5.3% y-o-y increase in 2Q 2020 to S$28.2 million, and  an  increase  of  4.9%  to  S$56.0  million  in  1H  2020.  Similarly,  the  reported  amount available for distribution grew by 5.2% y-o-y in 2Q 2020 and 5.4% in 1H 2020.

 

05.09.20 08:30

3263 Postings, 2521 Tage XaropePLife: joins FTSE EPRA NAREIT Global Developed Ind

Parkway Life Reit joins FTSE EPRA NAREIT Global Developed Index

https://www.businesstimes.com.sg/...pra-nareit-global-developed-index

PARKWAY Life (PLife) Reit will be included in the FTSE EPRA NAREIT Global Developed Index after the close of business on Sept 18, it said on Thursday.

The index is a leading benchmark index for listed real estate investment companies and Reits worldwide; it was developed by FTSE Russell in collaboration with the European Public Real Estate Association (EPRA), the European association for listed real estate, as well as the National Association of Real Estate Investment Trusts (NAREIT), a US-based association for Reits and publicly-traded real estate companies.


 

12.12.20 08:24

3263 Postings, 2521 Tage XaropePLife: Acquisition of a nursing home Japan

30.01.21 08:19

3263 Postings, 2521 Tage XaropePLife: Full Yearly Results 31/12/2020

24.04.21 08:28

3263 Postings, 2521 Tage XaropePLife: Annual General Meeting

Annual General Meeting
1. Results of AGM
2. Presentation Slides

https://links.sgx.com/1.0.0/...e07b9ee9c5016d624b724e09675f2f0dddde0f  

20.06.21 08:57

3263 Postings, 2521 Tage XaropePLife: DBS-SGX-REITAS Conference

Investor Presentation Slides
DBS-SGX-REITAS Conference
June 18, 2021

https://links.sgx.com/1.0.0/...f0dab8cdc31e8df63fc32aaa91bcee20f14789  

23.06.21 19:21

69 Postings, 1183 Tage aoliver84Hallo

Hallo zusammen, ich habe mich heute auch hier eingekauft. Gibt es ein Grund warum man in Malaysia so schwach vertreten ist? Welche Wachstumsstrategie fährt man dort?  

23.06.21 23:28

3263 Postings, 2521 Tage XaropePLife: hallo

Hi
Keine ahnung, plife ist natürlich drauf aus weiter zu wachsen, aber was da im einzelnen geplant ist ....
Ich mein irgendwo stand glaub auch ma was zum wachstum in deren pdfs, habs aber jetzt nicht gefunden.  

25.06.21 18:02

69 Postings, 1183 Tage aoliver84Fragen

Du hast dich ja schon einige Zeit mit Parkway beschäftigt, weißt du ob sie die Immobilien nach Laufzeit abschreiben?? Weißt du auch nach welchem Standart die bilanzieren, in der Bilanz hatte ich noch nichts gefunden, IFRS wird es wohl nicht sein.  

25.06.21 19:29

3263 Postings, 2521 Tage XaropePLife: sry

Sry zu bilanziellen sachen will ich keine aussagen machen.
Ich kenn mich im grundsatz mit aus, aber um nixs falsches zu sagen halt ich mich da lieber immer bedeckt.
Deshalb post ich meist nur die news die ich find ohne eigene wertungen.

Ich mein nur ne handvoll gehören ihnen zu voll, bei den anderen halten se beteiligungen.
(Sitzt grad bei meinem pizza ruminär aufn bier, grad nicht ganz sicher)  

11.12.21 08:23

3263 Postings, 2521 Tage XaropePLife: acquisition of nursing home located in japa

29.01.22 08:50

3263 Postings, 2521 Tage XaropePLife: Full Yearly Results 31/12/2021

   Antwort einfügen - nach oben